Back to News
Market Impact: 0.12
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
Source: Business Wire
Healthcare & BiotechPrivate Markets & Venture
Lōkahi Therapeutics renewed its collaboration with the University of Alabama to advance real-world asset evaluation and support development of future biopharma talent. The announcement signals continued investment in research capabilities and workforce development, but provides no financial terms, clinical data, or near-term commercial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.22
More News
- Oracle Kicks Off $20 Billion Capital Raise
- Blackstone president calls for more equity to fund AI buildout as debt risks mount
- Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Anthropic to Spend $895 Billion in the Years Ahead
- OpenAI deepens Abu Dhabi foothold as Sam Altman inks deals spanning energy, government and investment